New device aims to clean blood of burn toxins

NCT ID NCT07248930

Recruiting now Disease control Sponsor: Efferon JSC Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a device called Efferon LPS NEO that filters the blood of children with severe burns to remove harmful substances. The goal is to see if it reduces time in the ICU and improves recovery. Thirty children will receive the treatment and be compared to past cases.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Efferon LPS NEO device (blood filter that removes toxins and inflammatory substances)
What this could lead to: If it works, this could point toward a way to reduce ICU time and improve recovery for children with severe burns.
What could go wrong: This is a very small pilot study (30 participants) with no control group, so results may not be reliable. The device is experimental and may not improve outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BURNS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

burn

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BURNS

Contacts and locations

Locations

Children's City Clinical Hospital No. 9 named after G.N. Speransky of the Moscow City Health Department
RECRUITING

Moscow, 123317, Russia
Children's municipal multi-specialty clinical center of high medical technology
RECRUITING

Saint Petersburg, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.